JP2015522584A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522584A5 JP2015522584A5 JP2015519347A JP2015519347A JP2015522584A5 JP 2015522584 A5 JP2015522584 A5 JP 2015522584A5 JP 2015519347 A JP2015519347 A JP 2015519347A JP 2015519347 A JP2015519347 A JP 2015519347A JP 2015522584 A5 JP2015522584 A5 JP 2015522584A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- substitution
- sequence
- salt
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 27
- 102000004196 processed proteins & peptides Human genes 0.000 claims 27
- 108090000765 processed proteins & peptides Proteins 0.000 claims 27
- 238000006467 substitution reaction Methods 0.000 claims 22
- 150000001413 amino acids Chemical class 0.000 claims 18
- 150000003839 salts Chemical class 0.000 claims 15
- 229940024606 amino acid Drugs 0.000 claims 12
- 235000001014 amino acid Nutrition 0.000 claims 12
- 238000012986 modification Methods 0.000 claims 8
- 230000004048 modification Effects 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 239000000825 pharmaceutical preparation Substances 0.000 claims 7
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 6
- 210000001744 T-lymphocyte Anatomy 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 4
- 210000004899 c-terminal region Anatomy 0.000 claims 4
- 238000012217 deletion Methods 0.000 claims 4
- 230000037430 deletion Effects 0.000 claims 4
- 235000018102 proteins Nutrition 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 241000218645 Cedrus Species 0.000 claims 3
- 241000218691 Cupressaceae Species 0.000 claims 3
- 206010020751 Hypersensitivity Diseases 0.000 claims 3
- 230000007815 allergy Effects 0.000 claims 3
- 239000004475 Arginine Chemical class 0.000 claims 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 2
- 239000004471 Glycine Substances 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical class NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical class OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- 239000004472 Lysine Substances 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Chemical class OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 229960001230 asparagine Drugs 0.000 claims 2
- 235000009582 asparagine Nutrition 0.000 claims 2
- 229940009098 aspartate Drugs 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical class N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 229930195712 glutamate Chemical class 0.000 claims 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 229960000310 isoleucine Drugs 0.000 claims 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 2
- 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1211586.1 | 2012-06-29 | ||
| GBGB1211586.1A GB201211586D0 (en) | 2012-06-29 | 2012-06-29 | Japanese cedar peptides for preventing or treating allergy |
| PCT/GB2013/051733 WO2014001820A1 (en) | 2012-06-29 | 2013-06-28 | Japanese cedar peptide for preventing or treating allergy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015522584A JP2015522584A (ja) | 2015-08-06 |
| JP2015522584A5 true JP2015522584A5 (https=) | 2016-08-12 |
Family
ID=46721641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015519347A Pending JP2015522584A (ja) | 2012-06-29 | 2013-06-28 | アレルギーを予防又は治療するためのスギペプチド |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2015522584A (https=) |
| CN (1) | CN104602698A (https=) |
| GB (1) | GB201211586D0 (https=) |
| WO (1) | WO2014001820A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102156006B1 (ko) * | 2016-06-21 | 2020-09-15 | 다이호야쿠힌고교 가부시키가이샤 | 신규 삼나무 화분 단백질 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000005350A1 (en) * | 1998-07-24 | 2000-02-03 | Washington State University Research Foundation | Recombinant dehydrodiconiferyl alcohol benzylic ether reductase, and methods of use |
| JP3704577B2 (ja) * | 2000-08-17 | 2005-10-12 | 明治乳業株式会社 | 新規なスギ花粉アレルゲンタンパク質をコードする核酸分子 |
| GB201002559D0 (en) * | 2010-02-15 | 2010-03-31 | Circassia Ltd | Birch peptides for vaccine |
-
2012
- 2012-06-29 GB GBGB1211586.1A patent/GB201211586D0/en not_active Ceased
-
2013
- 2013-06-28 JP JP2015519347A patent/JP2015522584A/ja active Pending
- 2013-06-28 CN CN201380045182.8A patent/CN104602698A/zh active Pending
- 2013-06-28 WO PCT/GB2013/051733 patent/WO2014001820A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2839880T3 (es) | Vacuna contra el VRS | |
| HRP20201973T1 (hr) | Ligandi modificirani kružnom permutacijom kao agonisti i antagonisti | |
| AR105616A1 (es) | Proteínas de fusión | |
| JP2011528222A5 (https=) | ||
| JP2010522540A5 (https=) | ||
| FI2970398T3 (fi) | Rsv f -prefuusioproteiineja ja niiden käyttö | |
| JP2013517783A5 (https=) | ||
| JP2015504052A5 (https=) | ||
| AR105816A2 (es) | Derivados de exendina-4 funcionalizada | |
| HRP20221531T1 (hr) | Pripravci faktora viii i postupci dobivanja i korištenja istih | |
| FI3256579T3 (fi) | Kysteiiniproteaasi | |
| BR112016002939A2 (pt) | composições farmacêuticas parenterais aquosas estáveis de peptídeos insulinotrópicos | |
| CY1116099T1 (el) | Πρωτεϊνη συντηξης κατα του καρκινου | |
| JP2008536483A5 (https=) | ||
| JP2008530245A5 (https=) | ||
| JP2012510431A5 (https=) | ||
| JP2012505902A5 (https=) | ||
| RU2015144632A (ru) | Терапевтические пептиды | |
| JP2019533722A5 (https=) | ||
| JP2011508742A5 (https=) | ||
| NZ608502A (en) | Polypeptides that bind to human complement component c5 | |
| JP2012530761A5 (https=) | ||
| RU2012123642A (ru) | Аналоги инсулина, содержащие хлорированные аминокислоты | |
| SI2797950T1 (en) | Fusion protein against cancer | |
| JP2010508030A5 (https=) |